Everolimus in metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients (pts) with one versus two prior vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapies enrolled in the phase III RECORD-1 study Meeting Abstract
| Authors: | Figlin, R. A.; Calvo, E.; Motzer, R. J.; Hutson, T. E.; Oudard, S.; Porta, C.; Grunwald, V.; Ravaud, A.; Kpamegan, E. |
| Abstract Title: | Everolimus in metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients (pts) with one versus two prior vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapies enrolled in the phase III RECORD-1 study |
| Meeting Title: | 2011 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2011 Feb 17-19 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-03-01 |
| Language: | English |
| ACCESSION: | WOS:000208880700304 |
| DOI: | 10.1200/jco.2011.29.7_suppl.304 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 304 -- Source: Wos |
